Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

SBC Medical Group Holdings (SBCWW) Consolidated Net Income (2023 - 2025)

Historic Consolidated Net Income for SBC Medical Group Holdings (SBCWW) over the last 3 years, with Q3 2025 value amounting to $12.8 million.

  • SBC Medical Group Holdings' Consolidated Net Income rose 35275.98% to $12.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $31.1 million, marking a year-over-year decrease of 4077.54%. This contributed to the annual value of $32.3 million for FY2024, which is 1630.63% down from last year.
  • As of Q3 2025, SBC Medical Group Holdings' Consolidated Net Income stood at $12.8 million, which was up 35275.98% from $2.4 million recorded in Q2 2025.
  • SBC Medical Group Holdings' 5-year Consolidated Net Income high stood at $21.5 million for Q1 2025, and its period low was -$5.7 million during Q4 2024.
  • Over the past 3 years, SBC Medical Group Holdings' median Consolidated Net Income value was $8.1 million (recorded in 2023), while the average stood at $8.4 million.
  • Data for SBC Medical Group Holdings' Consolidated Net Income shows a peak YoY increase of 782494.33% (in 2024) and a maximum YoY decrease of 13660.81% (in 2024) over the last 5 years.
  • SBC Medical Group Holdings' Consolidated Net Income (Quarter) stood at $15.6 million in 2023, then crashed by 136.61% to -$5.7 million in 2024, then surged by 324.58% to $12.8 million in 2025.
  • Its last three reported values are $12.8 million in Q3 2025, $2.4 million for Q2 2025, and $21.5 million during Q1 2025.